ProteoDesign has closed a round of financing lead by Caixa Capital Risc. These funds will allow ProteoDesign to complete the first phase of its ADC development program. ”la Caixa” participates in this operation through the Caixa Innvierte BioMed II fund.
- Miquel Vila-Perelló interviewed by the CataloniaBio newsletter
- ProteoDesign leads the ToxAb consortium awarded with a “RETOS de Colaboración” grant
- ProteoDesign attends 2015 BIO International Convention
- “La Caixa” invests in ProteoDesign
- ProteoDesign participates in the Falling Walls 2014 meeting in Berlin